Scleroderma

Showing 1 - 25 of 124

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Scleroderma, Systemic Sclerosis Trial in Çankaya (Self Management Intervention Program)

Completed
  • Scleroderma
  • Systemic Sclerosis
  • Self Management Intervention Program
  • Çankaya, Ankara, Turkey
    Hacettepe University
Oct 19, 2023

Microstomia, Scleroderma Trial (Hyaluronidase, co2 laser)

Not yet recruiting
  • Microstomia
  • Scleroderma
  • (no location specified)
Aug 16, 2023

Interstitial Lung Disease, Scleroderma Trial in Assiut (Rituximab, IL6 inhibitor)

Completed
  • Interstitial Lung Disease
  • Scleroderma
  • Assiut, Yes, Egypt
    Manal Hassanien
Jul 18, 2023

Systemic Sclerosis, Scleroderma Trial in Worldwide (Anifrolumab (blinded), Placebo (blinded), Anifrolumab (unblinded, open

Not yet recruiting
  • Systemic Sclerosis
  • Scleroderma
  • Anifrolumab (blinded)
  • +2 more
  • Birmingham, Alabama
  • +130 more
Jun 22, 2023

Scleroderma, Calcinosis Cutis Trial (Extracorporeal Shock Wave Therapy (ESWT), PNF)

Not yet recruiting
  • Scleroderma
  • Calcinosis Cutis
  • Extracorporeal Shock Wave Therapy (ESWT)
  • PNF
  • (no location specified)
May 12, 2023

Co-designing Digital Ulcers Opportunities With Patients and

Not yet recruiting
  • Scleroderma
  • +2 more
  • No intervention
  • (no location specified)
Mar 24, 2023

Scleroderma, Scleroderma, Systemic, Systemic Sclerosis Trial in Montreal (SPIN-CHAT Program)

Completed
  • Scleroderma
  • +2 more
  • SPIN-CHAT Program
  • Montreal, Quebec, Canada
    Sir Mortimer B. Davis Jewish General Hospital
May 2, 2022

Rheumatoid Arthritis, Autoimmune Rheumatologic Disease, Systemic Lupus Erythematosus Trial in Québec (COVID-19 vaccine)

Recruiting
  • Rheumatoid Arthritis
  • +8 more
  • COVID-19 vaccine
  • Montréal, Quebec, Canada
  • +1 more
Jan 13, 2023

Rheumatoid Arthritis, Ankylosing Spondylitis, Fibromyalgia Trial in Upper Nyack

Recruiting
  • Rheumatoid Arthritis
  • +12 more
    • Upper Nyack, New York
      Global Healthy Living Foundation
    Dec 23, 2022

    A Single-Site Tissue Repository Providing Annotated Biospecimens

    Recruiting
    • Age-Related Macular Degeneration
    • +46 more
    • Specimen sample
    • Waltham, Massachusetts
      Sanguine Biosciences
    Nov 22, 2022

    Scleroderma Trial in Granada (Cognitive behavioral therapy)

    Enrolling by invitation
    • Scleroderma
    • Cognitive behavioral therapy
    • Granada, Spain
      Universidad de Granada
    Nov 16, 2022

    Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis Trial (Hyperoxia)

    Not yet recruiting
    • Interstitial Lung Disease
    • +4 more
    • Hyperoxia
    • (no location specified)
    Nov 1, 2022

    Pregnancy and Medically Assisted Conception in Rare Diseases

    Recruiting
    • Rheumatoid Arthritis
    • +10 more
      • Paris, France
        Hôpital Cochin
      Oct 31, 2022

      Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH

      Recruiting
      • Scleroderma
      • Pulmonary Artery Hypertension
        • Baltimore, Maryland
          Johns Hopkins
        Oct 20, 2022

        Scleroderma, Systemic Sclerosis Trial in France (clopidogrel treatment, Placebo)

        Recruiting
        • Scleroderma
        • Systemic Sclerosis
        • clopidogrel treatment
        • Placebo
        • Bordeaux, France
        • +8 more
        Oct 17, 2022

        Scleroderma, System; Sclerosis Trial in Antalya (Upper Extremity Home Exercises)

        Completed
        • Scleroderma
        • System; Sclerosis
        • Upper Extremity Home Exercises
        • Antalya, Turkey
          Antalya Training and Research Hospital
        Oct 11, 2022

        Scleroderma Registry

        Completed
        • Systemic Sclerosis
        • Scleroderma
          • Houston, Texas
            University of Texas - Houston Medical School
          Sep 26, 2022

          Scleroderma Trial in Ann Arbor (Resilience-based, Energy Management to Enhance Wellbeing (RENEW))

          Completed
          • Scleroderma
          • Resilience-based, Energy Management to Enhance Wellbeing (RENEW)
          • Ann Arbor, Michigan
            University of Michigan
          Sep 21, 2022

          Scleroderma, Mildly Elevated Pulmonary Pressures Trial in New Orleans, Baltimore (Sildenafil, Placebo)

          Recruiting
          • Scleroderma
          • Mildly Elevated Pulmonary Pressures
          • New Orleans, Louisiana
          • +1 more
          Sep 8, 2022

          Scleroderma, Systemic Sclerosis Trial in Montréal (SPIN-SELF Program)

          Recruiting
          • Scleroderma
          • Systemic Sclerosis
          • SPIN-SELF Program
          • Montréal, Quebec, Canada
            Jewish General Hospital
          Aug 15, 2022

          Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

          Recruiting
          • Rare Disorders
          • +309 more
            • Sioux Falls, South Dakota
            • +1 more
            Jun 20, 2022

            Scleroderma Trial in Murray (UVA-1 Phototherapy)

            Recruiting
            • Scleroderma
            • UVA-1 Phototherapy
            • Murray, Utah
              University of Utah MidValley Dermatology
            May 20, 2022

            Investigate the Physiopathology of Systemic Autoimmune Diseases

            Recruiting
            • Lupus Erythematosus
            • +4 more
            • Blood sampling
            • Toulouse, France
              Purpan University Hospital
            May 17, 2022

            Scleroderma, Cardiac Involvement, Autologous Stem Cell Transplantation Trial in Tuebingen (Autologous stemcell transplantation

            Active, not recruiting
            • Scleroderma
            • +2 more
            • Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells
            • Tuebingen, Germany
              University Hospital Tuebingen; Department of oncology, hematolog
            May 16, 2022

            Diffuse Cutaneous Systemic Sclerosis, Scleroderma, dcSSc Trial in Canada, United States (Brentuximab Vedotin, Placebo)

            Recruiting
            • Diffuse Cutaneous Systemic Sclerosis
            • +2 more
            • Brentuximab Vedotin
            • Placebo
            • Los Angeles, California
            • +9 more
            May 12, 2022